Healthcare

Eli Lilly and Co. (LLY) and Nektar Therapeutics (NKTR) Monday announced a strategic collaboration to co-develop NKTR-358, an immunological therapy discovered by Nektar. Compound is intended to reat a number of autoimmune and other chronic inflammatory conditions. Under the terms of the agreement, Nektar will receive an initial payment of $150 million and is eligible […]

At Panelav, Halol Alembic Pharmaceutical has inaugurated its state-of-the-art Anti-Cancer Manufacturing Facility at Panelav, Halol. The Rs 300 crore oncology manufacturing facility has an initial manufacturing capacity of 60 million tablets/ capsules and approximately 20 million vials of liquid injectable and lyophilised concentrates. http://www.business-standard.com/article/news-cm/alembic-pharmaceutical-inaugurates-oncology-manufacturing-facility-117071401123_1.html

Malaysian private equity firm Creador has acquired a minority stake in Paras Healthcare through affiliate Commelina for Rs 275 crore ($42 million). This is Creador’s 24th investment globally (9th in India). Anand Narayan, managing director, Creador Advisors India LLP, said “Paras Healthcare, hospital infrastructure and operations are all developed to provide the best healthcare services […]

Novartis has announced that the US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) unanimously (10-0) recommended approval of CTL019 (tisagenlecleucel), an investigational chimeric antigen receptor T cell (CAR-T) therapy, for the treatment of relapsed or refractory (r/r) pediatric and young adult patients with B-cell acute lymphoblastic leukemia (ALL). “The panel’s unanimous recommendation […]

Novanta, a trusted technology partner to medical and advanced technology equipment manufacturers, has announced the closing of its acquisition of World of Medicine GmbH (World of Medicine) for €115 million in cash. World of Medicine, based in Berlin, Germany, is the leading supplier to original equipment manufacturers (“OEMs”) of regulatory controlled medical insufflators, pumps, and […]

HealthIntel Services, an online-offline pharmacy model in north India, has raised an undisclosed amount of funding from BLIP Initiatives, a start-up accelerator in the health, beauty and wellness space. BLIP is one of its kind start-up accelerators. The year-old accelerator was setup by SC Sehgal a veteran industrialist with interests in pharma, beauty and wellness […]

Sun Pharma and Samsung BioLogics on Tuesday announced a strategic long-term manufacturing agreement for Tildrakizumab used for treatment of psoriasis. “The agreement was entered into by Sun Pharma’s wholly- owned subsidiary and Samsung BioLogics…Sun Pharma has appointed Samsung BioLogics to manufacture Tildrakizumab, an investigational IL-23p19 inhibitor being evaluated for the treatment of moderate to severe […]

Sun Pharma and Samsung BioLogics on Tuesday announced a strategic long-term manufacturing agreement for Tildrakizumab used for treatment of psoriasis. “The agreement was entered into by Sun Pharma’s wholly- owned subsidiary and Samsung BioLogics…Sun Pharma has appointed Samsung BioLogics to manufacture Tildrakizumab, an investigational IL-23p19 inhibitor being evaluated for the treatment of moderate to severe […]

Union government has prepared the detailed project report (DPR) for AIIMS to be set up at Devipur in Jharkhand’s Deoghar district, which is expected to start functioning in about two-and-a-half years. Jharkhand Health, Medical Education and Family Welfare Minister Ramchandra Chandravanshi told a press conference here today that the state government has received report that […]

Stent manufacturers want the government to apply differential pricing for drug-eluting stents by classifying them on the basis of technology used. Such a move will reward quality and innovation to keep the segment viable while also giving physicians broader treatment options, according to two industry bodies — AdvaMed and MTaI. Drug-eluting stents (DES) have a […]